Previous studies showed ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies [46] and provided evidence that UBQLN2 dysregulation may contribute to α-synuclein-mediated toxicity [47]. This evidence concerns the gene SNCA and synucleinopathy.